Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 97, Issue 1, 1997, Pages 107-112

  Demeter, Judith ^a   Porzsolt, Franz ^a   Rämisch, Stephanie ^b   Schmidt, Dorothee ^b   Schmid, Mathias ^a   Messer, Gerald ^b,c  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

chronic lymphocyte leukaemia; genetic association; lymphotoxin; polymorphism; tumour necrosis factor

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030934737     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.9912636.x     Document Type: Article

References (37)

1. Abraham, L.J., French, M.A. & Dawkins, R.L. (1993) Polymorphic ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clinical and Experimental Immunology, 92, 14-18.
2. Albertella, M.R. & Campbell, R.D. (1994) Characterization of a novel gene in the human major histocompatibility complex that encodes a potential new member of the I kappa B family of proteins. Human Molecular Genetics, 3, 793-799.
3. Alvarez-Mon, M., Garcia-Suarez, J., Prieto, A., Manzano, L., Reyes, E., Lorences, C., Peraile, G., Jorda, J. & Durantez, A. (1993) Heterogenous proliferative effect of tumor necrosis factor-α and lymphotoxin on mitogen-activated B cells from B-chronic lymphocytic leukemia. American Journal of Hematology, 43, 81-85.
4. Binet, J.L., Auguier, A., Dighiero, G., Chastang, C., Piguet, H., Goasquen, J., Vangier, G., Pytron, G., Polona, P., Oberling, F., Thomas, M., Tehernia, G., Jacquillat, C., Boirin, P., Lesty, C., Dulat, M.T. & Gremy, F. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from multivariate survival analysis. Cancer, 48, 198-206.
5. Boussiotis, V.A., Nadler, L.M., Strominger, J.L. & Goldfeld, A.E. (1994) Tumor necrosis factor α is an autocrine growth factor for normal human B cells. Proceedings of the National Academy of Sciences of the United States of America, 91, 7007-7011.
6. Buck, C., Digel, W., Schöniger, W., Stefanic, M., Raghavachar, A., Heimpel, H. & Porzsolt, F. (1990) Tumor necrosis factor alpha but not lymphotoxin, stimulates growth of tumor cells in hairy cell leukaemia. Leukemia, 4, 431-434.
7. Conley, C.L., Misiti, J. & Laster, A.J. (1980) Genetic factors predisposing to chronic lymphocytic leukaemia and to autoimmune disease. Medicine, 59, 323-334.
8. Cordingley, F.T., Hoffbrand, A.V., Heslop, H.E., Vyakarnam, A., Turner, M., Meager, A. & Brenner, M.K. (1988) Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet, i, 969-971.
9. Cuttner, J., Skerrett, D., Rosina, O., Troy, K.M., Wallenstein, S. & Spivack, M. (1994) Increased incidence of HLA antigen B35 in patients with chronic lymphocytic leukemia. Leukemia Research, 8, 565-567.
10. D'Alfonso, S. & Richiardi, P.M. (1994) A polymorphic variation in a putative regulation box of the TNF alpha promoter region. Immunogenetics, 39, 150-154.
11. Digel, W., Stefanic, M., Schöniger, W., Buck, C., Raghavachar, A., Frickhofen, R., Heimpel, H. & Porzsolt, F. (1989) Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood, 73, 1242-1246.
12. Dührsen, U., Augener, W., Zwingers, T. & Brittinger, G. (1987) Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases. British Journal of Haematology, 67, 235-239.
13. Estrov, Z., Kurzrock, R., Pocsik, E., Pathak, S., Kantarijan, H.M., Zipf, T.F., Harris, D., Talpaz, M. & Aggarwal, B.B. (1993) Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines. Journal of Experimental Medicine, 177, 763-774.
14. Eugster, H.P., Müller, M., Karrer, U., Car, B.D., Schnyder, B., Eng, V.M., Woerly, G., Le Hir, M., di Padova, F., Aguet, M., Zinkernagel, M., Bluethmann, H. & Ryffel, B. (1996) Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice. International Immunology, 8, 23-36.
15. Foa, R., Massaia, M., Cardona, S., Tos, A.G., Bianchi, A., Attisano, C., Guarini, A., di Celle, P.F. & Fierro, M.T. (1990) Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease. Blood, 76, 393-400.
16. Goldfeld, A.E., Strominger, J.L. & Doyle, C. (1991) Human tumor necrosis factor α gene regulation in phorbol ester stimulated T and B cell lines. Journal of Experimental Medicine, 174, 73-81.
17. Holzinger, I., de Baey, A., Messer, G., Kick, G., Zwierzina, H. & Weiss, E.H. (1995) Cloning and genomic characterization of LST1: a new gene in the human TNF region. Immunogenetics, 42, 315-322.
18. Jabbar, S.A.B., Hoffbrand, A.V. & Wickremasinghe, R.G. (1994) Regulation of transcription factors NFkB and AP-1 following tumour necrosis factor-α treatment of cells from chronic B cell leukaemia patients. British Journal of Haematology, 86, 496-504.
19. Jacob, C.O., Fronek, Z., Lewis, G.D., Koo, M., Hansen, J.A. & McDevitt, H.O. (1990) Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor-α: relevance to genetic predisposition to systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the United States of America, 87, 1233-1237.
20. McGuire, W., Hill, A.V., Allsopp, C.E.M., Greenwood, B.M. & Kwiatkowski, D. (1994) Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature, 371, 508-511.
21. Messer, G., Kick, G., Ranki, A., Koskimies, S., Reunala, T. & Meurer, M. (1994) Polymorphism of the tumor necrosis factor genes in patients with dermatitis herpetiformis. Dermatology, 189S, 135-137.
22. Messer, G., Spengler, U., Jung, M.C., Honold, G., Blömer, K., Pape, G.R., Riethmüller, G. & Weiss, E.H. (1991) Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. Journal of Experimental Medicine, 173, 209-219.
23. Messer, G., Weiss, E.H. & Baeuerle, P. (1990) Tumor necrosis factor β (TNF-β) induces binding of the NF-kB transcription factor to a high-affinity kB element in the TNF-β promoter. Cytokine, 2, 389-377.
24. Nedospasov, S.A., Shakhov, A.N., Turetskaya, R.L., Mett, V.A., Azizov, M.M., Georgiev, G.P., Korobko, V.G., Dobrynin, V.N., Filippov, S.A., Bystrov, N.S., Boldyreva, E.F., Chupvilo, S.A., Chumakov, A.M., Shingarova, L.N. & Ovchinnikov, Y.A. (1986) Tandem rearrangement of genes coding for tumor necrosis factor (TNF-α) and lymphotoxin (TNF-β) in the human genome. Cold Spring Harbor Symposia on Quantitative Biology, 51, 611-624.
25. Partanen, J. & Koskimies, S. (1988) Low degree of DNA polymorphism in the HLA-linked lymphotoxin (tumor necrosis factor β) gene. Scandinavian Journal of Immunology, 28, 313-316.
26. Pociot, F., Briant, L., Jongeneel, C.V., Molvig, J., Worsaae, H., Abbal, M., Thomsen, M., Nerup, J. & Chambon-Thomsen, A. (1993) Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. European Journal of Immunology, 23, 224-231.
27. Rai, K.R., Sawitsky, A., Cronkite, E.P., Chandau, A.D., Levy, A.N. & Pasternack, B.S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, 219-234.
28. Schmid, M., Schrezenmeier, H., Staib, G. & Porzsolt, F. (1995) Evidence for a paracrine pathway of B-cell stimulation in hairy cell leukaemia. British Journal of Haematology, 90, 156-162.
29. Schuchmann, M., Hess, S., Bufler, P., Brakebusch, C., Wallach, D., Porter, A., Riethmüller, G. & Engelmann, H. (1995) Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactions. European Journal of Immunology, 25, 2183-2189.
30. Spies, T., Blanck, G., Bresnahan, M., Sands, J. & Strominger, J.L. (1989) A new cluster of genes within the human major histocompatibility complex. Science, 243, 214-217.
31. Tos, A.G., Cignetti, A., Rovera, G. & Foa, R. (1996) Retroviral vector-mediated transfer of the tumor necrosis factor-α gene into human cancer cells restores an apoptotic cell death program and induces a bystander-killing effect. Blood, 87, 2486-2495.
32. van Kooten, C., Rensink, I., Aarden, L. & van Oers, R. (1993) Cytokines and intracellular signals involved in the regulation of B-CLL proliferation. Leukemia and Lymphoma, 12, 27-33.
33. Waage, A., Liabakk, N., Lien, E., Lamvik, J. & Espevik, T. (1992) p55 and p75 tumor necrosis factor receptors in patients with chronic lymphocytic leukemia. Blood, 80, 2577-2583.
34. Wilson, A.G., de Vries, N., Pociot, F., di Giovine, F.S., van der Putte, L.B.A. & Duff, G.W. (1993) An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8 and DR3 alleles. Journal of Experimental Medicine, 177, 577-560.
35. Wilson, A.G., di Giovine, F.S. & Duff, G.W. (1995) Genetics of tumor necrosis factor-α in autoimmune, infectious, and neoplastic diseases. Journal of Inflammation, 45, 1-12.
36. Wilson, A.G., Symons, J.A., McDowell, T.L., di Giovine, F.S. & Duff, G.W. (1994) Effects of a tumour necrosis factor promoter base transition on transcriptional activity. British Journal of Rheumatology, 33S, 89.
37. + T cells. Annals of Neurology, 38, 723-730.